Close

Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDA

Go back to Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDA
Medivation, Inc. (NASDAQ: MDVN) Delayed: 81.44 --0 (-0%)
Previous Close $81.44    52 Week High $81.48 
Open $3852.47    52 Week Low $26.41 
Day High $81.44    P/E N/A 
Day Low $81.44    EPS $-1.03 
Volume 13,593